India to United States: Ezetimibe Export Trade Route
India has recorded 418 verified shipments of Ezetimibe exported to United States, representing a combined trade value of $221.5M USD. This corridor is served by 15 active Indian exporters, with an average shipment value of $530.0K USD. The leading Indian exporter is PIRAMAL PHARMA LIMITED, which accounts for 49% of total export value with 50 shipments worth $108.7M USD. On the buying side, PCI PHARMA SERVICES is the largest importer in United States with $108.2M USD in purchases. The top 3 suppliers — PIRAMAL PHARMA LIMITED, ALKEM LABORATORIES LIMITED, ZYDUS LIFESCIENCES LIMITED — together control 97% of total trade value on this route. All data sourced from Indian Customs (DGFT) shipping bill records. Values reported in FOB USD.

Route Intelligence Overview
The India to United States Ezetimibe corridor is one of India's established pharmaceutical export routes, with 418 shipments documented worth a combined $221.5M USD. The route is dominated by PIRAMAL PHARMA LIMITED, which alone accounts for roughly 49% of all export value, reflecting the consolidated nature of India's ezetimibe manufacturing sector.
Across 15 active suppliers, the average shipment value stands at $530.0K USD — a figure that reflects both bulk commercial orders from large pharmaceutical companies and smaller specialty shipments. Sea freight dominates at 84% of all shipments, consistent with ezetimibe's non-urgent bulk-order profile.
Shipment activity peaks during January–March, with an average transit time of 32 days port-to-port. The route has recorded an annual growth rate of 13.6%, placing it at rank #17 among India's top ezetimibe export destinations globally.
On the import side, key buyers of Indian ezetimibe in United States include PCI PHARMA SERVICES, ASCEND LABORATORIES LLC, ASCEND LABORATORIES,LLC and 31 others. PCI PHARMA SERVICES is the single largest importer with 24 shipments valued at $108.2M USD.
Route Characteristics
- Average transit32 days
- Peak seasonQ1
- Primary modeSea freight
- Top portDELHI AIR
Market Position
- Global rank#17
- Annual growth+13.6%
- Demand growth+13.8%
- Regulatory ease88/100
Top 10 Indian Ezetimibe Exporters to United States
Showing top 10 of 15 Indian suppliers exporting Ezetimibe to United States, ranked by total trade value (USD)
| Rank | Supplier (Indian Exporter) | Shipments | Total Value (USD) | Market Share |
|---|---|---|---|---|
| 1 | PIRAMAL PHARMA LIMITED Avg $2.2M per shipment | 50 | $108.7M | 49.1% |
| 2 | ALKEM LABORATORIES LIMITED Avg $503.7K per shipment | 207 | $104.3M | 47.1% |
| 3 | ZYDUS LIFESCIENCES LIMITED Avg $46.7K per shipment | 47 | $2.2M | 1.0% |
| 4 | AMNEAL PHARMACEUTICALS PRIVATE LIMITED Avg $58.3K per shipment | 30 | $1.7M | 0.8% |
| 5 | HETERO LABS LIMITED Avg $63.4K per shipment | 23 | $1.5M | 0.7% |
| 6 | GLENMARK PHARMACEUTICALS LIMITED Avg $50.5K per shipment | 12 | $605.6K | 0.3% |
| 7 | AUROBINDO PHARMA LIMITED Avg $140.7K per shipment | 4 | $562.7K | 0.3% |
| 8 | HETERO LABS LIMITED Avg $40.0K per shipment | 14 | $559.7K | 0.3% |
| 9 | WATSON PHARMA PRIVATE LIMITED Avg $46.4K per shipment | 9 | $417.2K | 0.2% |
| 10 | ALKEM LABORATORIES LTD Avg $36.3K per shipment | 10 | $363.0K | 0.2% |
This table shows the top 10 of 15 Indian companies exporting ezetimibe to United States, ranked by total trade value. The listed exporters are: PIRAMAL PHARMA LIMITED, ALKEM LABORATORIES LIMITED, ZYDUS LIFESCIENCES LIMITED, AMNEAL PHARMACEUTICALS PRIVATE LIMITED, HETERO LABS LIMITED, GLENMARK PHARMACEUTICALS LIMITED, AUROBINDO PHARMA LIMITED, HETERO LABS LIMITED, WATSON PHARMA PRIVATE LIMITED, ALKEM LABORATORIES LTD. PIRAMAL PHARMA LIMITED is the dominant supplier with 50 shipments worth $108.7M USD, giving it a 49% market share. The top 3 suppliers together account for 97% of the total trade value on this route.
Showing top 10 of 15 total Indian exporters on the India to United States Ezetimibe export route.
Top 10 Ezetimibe Importers in United States
Showing top 10 of 34 known buyers in United States receiving Ezetimibe shipments from India, ranked by import value
On the receiving end of this trade route, the leading importers of Indian ezetimibe in United States include PCI PHARMA SERVICES, ASCEND LABORATORIES LLC, ASCEND LABORATORIES,LLC, PRIORITY HEALTHCARE DISTRIBUTION DB, TO THE ORDER OF...., among 34 total buyers. The largest importer is PCI PHARMA SERVICES, accounting for $108.2M USD across 24 shipments — representing 49% of all ezetimibe imports from India on this route.
| Rank | Importer / Buyer | Shipments | Import Value (USD) | Market Share |
|---|---|---|---|---|
| 1 | PCI PHARMA SERVICES | 24 | $108.2M | 48.9% |
| 2 | ASCEND LABORATORIES LLC | 96 | $99.7M | 45.0% |
| 3 | ASCEND LABORATORIES,LLC | 90 | $4.0M | 1.8% |
| 4 | PRIORITY HEALTHCARE DISTRIBUTION DB | 10 | $914.8K | 0.4% |
| 5 | TO THE ORDER OF.... | 18 | $883.3K | 0.4% |
| 6 | EVERSANA LIFE SCIENCE SERVICES | 31 | $881.2K | 0.4% |
| 7 | AMNEAL PHARMACEUTICALS, LLC (KY) | 16 | $774.7K | 0.3% |
| 8 | TO THE ORDER OF | 13 | $659.2K | 0.3% |
| 9 | PRIORITY HEALTHCARE DISTRIBUTION | 7 | $647.1K | 0.3% |
| 10 | AMNEAL PHARMACEUTICALS LLC KY | 10 | $582.2K | 0.3% |
Showing top 10 of 34 Ezetimibe importers in United States on this route.
Top 10 Ezetimibe Formulations Imported by United States
Showing top 10 of 227 product formulations shipped on the India to United States Ezetimibe route, ranked by trade value
United States imports a wide range of ezetimibe formulations from India, spanning tablets, capsules, suspensions, and combination drugs. The top formulation — (431304001) BEMPEDOIC ACID AND EZETIMIBEFIXED DOSE COMBINATION TABLETS, BEMPEDOIC180MG+EZ10MG TABS(FDC)BULK PACK — accounts for $107.6M USD across 11 shipments. There are 227 distinct product descriptions in the dataset, reflecting the variety of dosage forms and strengths imported.
| Rank | Product Formulation | Shipments | Trade Value (USD) | Market Share |
|---|---|---|---|---|
| 1 | (431304001) BEMPEDOIC ACID AND EZETIMIBEFIXED DOSE COMBINATION TABLETS, BEMPEDOIC180MG+EZ10MG TABS(FDC)BULK PACK | 11 | $107.6M | 48.6% |
| 2 | EZETIMIBE TABLETS USP 10MG (EACH TAB CONT. EZETIMIBE USP 10MG) [12009 PACK X 500'S] (BATCH NO. 23123421, 23123626, 23123 | 1 | $59.5M | 26.9% |
| 3 | EZETIMIBE TABLETS USP 10MG (EACH TAB CONT. EZETIMIBE USP 10MG) [7416 PACK X 500'S] (BATCH NO. 23123672, 23123673 MFG DT. | 1 | $36.7M | 16.6% |
| 4 | EZETIMIBE TABLET | 12 | $805.5K | 0.4% |
| 5 | PHARMACEUTICAL MEDICINE FOR HUMAN USE- EZETIMIBE TAB USP 10 MG - 1 X 500 | 3 | $680.9K | 0.3% |
| 6 | PHARMACEUTICAL MEDICINE FOR HUMAN USE -EZETIMIBE TAB USP 10 MG - 1 X 500 | 7 | $647.1K | 0.3% |
| 7 | EZETIMIBE TABLETS 10 MG 90'S PACK | 2 | $485.7K | 0.2% |
| 8 | (431304001) BEMPEDOIC ACID AND EZETIMIBE FIXED DOSE COMBINATION TABLETS, BEMPEDOIC180MG+EZ10MG TABS(FDC)BULK | 9 | $424.4K | 0.2% |
| 9 | EZETIMIBE 10MG TABLET | 10 | $397.6K | 0.2% |
| 10 | EZETIMIBE TABLETS, USP 10 MG NDC 69238-1154-9 FDA PRODUCT CODE 61 J C A 15 ANDA# 208803 UNIT PACK 90 | 8 | $393.8K | 0.2% |
Showing top 10 of 227 Ezetimibe formulations imported by United States on this route.
Shipping & Logistics Analysis
Freight mode split and port-of-origin breakdown
Freight Mode Distribution
Sea freight dominates at 84%, typical for bulk pharmaceutical shipments.
Top Ports of Origin
DELHI AIR handles the highest volume with 53 shipments. Transit time averages 32 days by sea.
Market Dynamics
India's ezetimibe exports to United States are driven primarily by a handful of large-scale manufacturers. PIRAMAL PHARMA LIMITED with 50 shipments leads the pack, a pattern common in generic pharmaceutical corridors where manufacturing scale creates significant cost advantages. The presence of 15 active exporters signals a competitive but concentrated market — buyers in United States benefit from supplier diversity while the top tier handles the majority of volume.
The top 3 suppliers — PIRAMAL PHARMA LIMITED, ALKEM LABORATORIES LIMITED, ZYDUS LIFESCIENCES LIMITED — together account for 97% of total trade value on this route. The average shipment value of $530.0K USD reflects primarily bulk commercial orders from large pharmaceutical distributors.
Beyond the primary product category, shipments on this route include closely related formulations such as ezetimibe tablets usp 10mg (each tab cont. ezetimibe usp 10mg) [12009 pack x 500's] (batch no. 23123421, 23123626, 23123 and ezetimibe tablets usp 10mg (each tab cont. ezetimibe usp 10mg) [7416 pack x 500's] (batch no. 23123672, 23123673 mfg dt., suggesting that buyers in United States tend to consolidate orders across related product lines from the same Indian supplier.
On the buying side, PCI PHARMA SERVICES is the largest importer with 24 shipments worth $108.2M USD — representing 49% of all ezetimibe imports from India on this route. A total of 34 buyers are active on this corridor.
Route Statistics
- Trade Volume
- $221.5M
- Avg. Shipment
- $530.0K
- Suppliers
- 15
- Buyers
- 34
- Transit (Sea)
- ~32 days
- Annual Growth
- +13.6%
Reverse Direction
United States → India — Ezetimibe (Import)Other Ezetimibe Routes
Unlock the Full India to United States Ezetimibe Dataset
TransData Nexus provides verified shipment-level records, supplier contact details, HS code breakdowns, real-time pricing benchmarks, and regulatory compliance guides for 418 shipments on this route.
Frequently Asked Questions — India to United States Ezetimibe Trade
Answers based on Indian Customs (DGFT) shipment records compiled by TransData Nexus
Q Which Indian companies export Ezetimibe to United States?
The leading Indian exporters of Ezetimibe to United States are PIRAMAL PHARMA LIMITED, ALKEM LABORATORIES LIMITED, ZYDUS LIFESCIENCES LIMITED. PIRAMAL PHARMA LIMITED holds the largest market share at approximately 49% of total trade value on this route.
Q What is the total value of Ezetimibe exports from India to United States?
India exports Ezetimibe to United States worth approximately $221.5M USD across 418 recorded shipments. The average value per shipment is $530.0K USD.
Q Which ports does India use to ship Ezetimibe to United States?
The most active port of origin is DELHI AIR with 53 shipments. Indian exporters primarily use sea freight for this route, with 84% of shipments going by sea and 29% by air.
Q How long does shipping take from India to United States for Ezetimibe?
The average transit time for Ezetimibe shipments from India to United States is approximately 32 days. Sea freight typically takes longer, while air freight can reduce this significantly for urgent orders. Peak shipping activity is observed during January–March.
Q Is the India to United States Ezetimibe trade route growing?
Yes — this trade corridor has seen an annual growth rate of approximately 13.6% with demand growth tracking at 13.8%. The route is ranked #17 among India's top Ezetimibe export destinations globally.
Q How many suppliers are active on the India to United States Ezetimibe route?
There are currently 15 active Indian suppliers exporting Ezetimibe to United States. The market is moderately concentrated with PIRAMAL PHARMA LIMITED accounting for 49% of total shipment value.
Q Who are the main importers of Ezetimibe from India in United States?
The leading importers of Indian Ezetimibe in United States include PCI PHARMA SERVICES, ASCEND LABORATORIES LLC, ASCEND LABORATORIES,LLC, PRIORITY HEALTHCARE DISTRIBUTION DB, TO THE ORDER OF..... PCI PHARMA SERVICES is the largest buyer with 24 shipments worth $108.2M USD.
Official References & Regulatory Resources
- India Trade Statistics (DGFT)
- Invest India — Pharma Sector
- WCO HS Nomenclature
- Ministry of Commerce — Pharma Exports
- Pharmexcil
Data sourced from Indian Customs (DGFT) records. Verify regulatory and trade status with the agencies above.
Research Methodology & Data Transparency
Suresh Sormare
Verified AuthorPharmaceutical Export-Import Analyst & Trade Intelligence Expert
Suresh Sormare is a pharmaceutical export-import analyst with deep expertise in Indian Customs (DGFT) data, HS code classification, and global pharmaceutical supply chains. His analysis covers 10M+ shipment records across 150+ countries and is used by manufacturers, procurement agencies, and trade consultants worldwide. Suresh specializes in identifying verified suppliers and buyers from customs records, mapping bilateral pharmaceutical trade corridors, analyzing tariff structures and regulatory frameworks across 170+ destination markets, and benchmarking competitive positioning for finished pharmaceutical formulations. His methodology combines granular customs transaction data with regulatory intelligence from FDA, EMA, WHO, CDSCO, and 40+ national drug authorities to deliver actionable trade insights for the pharmaceutical formulations sector.
linkedin.com/in/sureshsormarePrimary Data Source
All trade data is sourced from Indian Customs (DGFT) official shipping bill records — the authoritative government database for India's pharmaceutical trade. Each verified record contains exporter name, consignee (buyer) name, detailed product description, quantity, declared FOB value (USD), port of loading, destination country, and shipment date.
Analysis Methodology
- 1.Route Identification: India to United States export trade corridor identified from Indian Customs (DGFT) records for Ezetimibe.
- 2.Supplier/Buyer Matching: 15 Indian exporters and 34 importers in United States matched using name normalization.
- 3.Value Aggregation: Total export value aggregated from 418 verified shipping bill records. Values are FOB in USD.
- 4.Market Share Analysis: Each supplier and buyer contribution calculated as a percentage of total route value. Statistical normalization applied to ensure accurate representation across varying shipment sizes.
Government-Sourced Data
Official DGFT customs records
Transparent Methodology
Calculations fully disclosed above
418 Verified Shipments
15 Indian exporters tracked
Expert-Reviewed
By pharmaceutical trade specialists